• The MEK inhibitors: trametinib and selumetinib

  • Feb 19 2021
  • Length: 41 mins
  • Podcast

The MEK inhibitors: trametinib and selumetinib

Listen for free

View show details

  • Summary

  • The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis. Link to Patreon

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The MEK inhibitors: trametinib and selumetinib

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available